SURRENINUM 200K (Seroyal USA)


Welcome to the PulseAid listing for the SURRENINUM 200K drug offered from Seroyal USA. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Seroyal USA
NON-PROPRIETARY NAME: Oryctolagus cuniculus (Rabbit) Adrenal Gland
SUBSTANCE NAME: ORYCTOLAGUS CUNICULUS ADRENAL GLAND
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2015-12-01
END MARKETING DATE: 0000-00-00


SURRENINUM 200K HUMAN OTC DRUG Details:

Item DescriptionSURRENINUM 200K from Seroyal USA
LABELER NAME: Seroyal USA
DEA SCHEDULE:
ACTIVE STRENGTH: 200([hp_C]/30mL)
START MARKETING DATE: 2015-12-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 62106-0305_25d9728f-6a5f-65ab-e054-00144ff8d46c
PRODUCT NDC: 62106-0305
APPLICATION NUMBER:

Other ORYCTOLAGUS CUNICULUS ADRENAL GLAND Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Seroyal USASURRENINUM